Abstract:Introduction: Erectile dysfunction (ED) is a common complication after radical prostatectomy (RP), and it seriously affects the quality of life in patients and their partners. The primary trigger of postoperative ED is surgical injury to the cavernous nerves that control penile erection and run along the anterolateral aspect of the prostate. Despite the introduction and ongoing innovation of nerve-sparing techniques, a significant number of patients still suffer from moderate cavernous nerve injury (CNI), which is thought to be transient and reversible. Therefore, early postoperative penile rehabilitation therapy may salvage patients' erectile function by promoting cavernous nerve regeneration and preventing penile structural alterations. Aims: To present a comprehensive overview of the current molecular pathogenesis of CNI-induced ED, as well as novel therapeutic strategies and their potential mechanisms. Methods: A literature search was performed using PubMed. Search terms included erectile dysfunction , cavernous nerve injury , pathogenesis , pathway , and treatment . Results: The NOS/NO pathway, oxidative stress-related pathway, RhoA/ROCK pathway, transforming growth factor-β (TGF-β), sonic hedgehog (Shh), and hydrogen sulfide (H 2 S) are involved in the molecular pathogenesis of CNI-induced ED. Multiple neurotrophins, including brain-derived nerve growth factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), and neurturin (NTN), were found to promote cavernous nerve regeneration. Emerging therapeutic approaches can be roughly summarized into four categories, namely small molecule and drug, stem cell-based therapy (SCT), micro-energy therapy and platelet-rich plasma (PRP) therapy. Conclusion: These pathways collectively lead to the irreversible damage to the penile structure after CNI. The combined early rehabilitation strategies of promoting upstream nerve regeneration and recovering abnormal molecular signals of downstream penis are presumed to save patients' erectile function after RP. In future studies, the cross-talk between these molecular pathways needs to be further clarified, and the questions of how denervation injury induces the molecular alterations in the penis also need to be addressed.

Neurotrophin and Erectile Dysfunction in Diabetes

The Multifaceted Nature of Diabetic Erectile Dysfunction: Uncovering the Intricate Mechanisms and Treatment Strategies

The Study of Multifactorial Pathogenesis of Diabetic Erectile Dysfunction

[Expression of Nerve Growth Factor in Cavernous Tissue and Its Effects on the Treatment of Rats with Diabetic Erectile Dysfunction].

Differential Expression Of Neurotrophins In Penises Of Streptozotocin-Induced Diabetic Rats

Cavernous Nerve Injury Resulted Erectile Dysfunction and Regeneration

Study on Effect of NGF in the Intervention of Erectile Dysfunction Induced by Diabetes Mellitus

Activation of the NGF/TrkA signaling pathway attenuates diabetic erectile dysfunction

Inhibition of Ninjurin 1 restores erectile function through dual angiogenic and neurotrophic effects in the diabetic mouse

Neutrophil extracellular traps promote erectile dysfunction in rats with diabetes mellitus by enhancing NLRP3-mediated pyroptosis

Advances in Pathogenesis and Treatment of Diabetic Erectile Dysfunction

[Vascular Factors in the Pathogenesis of Diabetic Erectile Dysfunction].

Establishment of in vitro model of erectile dysfunction for the study of high-glucose-induced angiopathy and neuropathy

Effects of Selective Endothelin Receptor Antagonist on Vegf Signaling System in Diabetic Penis: A Possible Clinical Implication for Diabetes Induced Erectile Dysfunction

Therapeutic Effects of Proanthocyanidins on Diabetic Erectile Dysfunction in Rats

[Expression of Neuronal Nitric Oxide Synthase in Corpus Cavernosum with Diabetic Erectile Dysfunction: Experiment with Rabbits].

Molecular pathogenesis and treatment of cavernous nerve injury-induced erectile dysfunction: A narrative review

Research Advances in Stem Cell Therapy for Erectile Dysfunction

The TGF‐β1/Smad/CTGF Pathway and Corpus Cavernosum Fibrous‐Muscular Alterations in Rats with Streptozotocin‐Induced Diabetes

Pancreatic Kininogenase Improves Erectile Function in Streptozotocin-Induced Type 2 Diabetic Rats with Erectile Dysfunction

Stem Cell Therapy for Erectile Dysfunction: A Critical Review